Inhibition of Integrin αvβ6 on Cholangiocytes Blocks Transforming Growth Factor-β Activation and Retards Biliary Fibrosis Progression
- 1 August 2008
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 135 (2) , 660-670
- https://doi.org/10.1053/j.gastro.2008.04.009
Abstract
No abstract availableKeywords
Funding Information
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320000-117725/1)
- European Association for the Study of the Liver
- National Institutes of Health (GRK-750, U19 AI066313)
- Deutsche Forschungsgemeinschaft
This publication has 53 references indexed in Scilit:
- Integrin αvβ6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapiesJournal of Hepatology, 2008
- Integrin structures and conformational signalingCurrent Opinion in Cell Biology, 2006
- αvβ6 integrin down-regulates the MMP-13 expression in oral squamous cell carcinoma cellsExperimental Cell Research, 2005
- Mdr2 (Abcb4)-/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genesJournal of Hepatology, 2005
- Immunohistochemical screening for β6‐integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up‐regulation in pancreatic ductal adenocarcinomas in vivo and in vitroHistopathology, 2004
- Loss of integrin αvβ6-mediated TGF-β activation causes Mmp12-dependent emphysemaNature, 2003
- Direct integrin αvβ6-ERK binding: implications for tumour growthOncogene, 2002
- The Activation Sequence of Thrombospondin-1 Interacts with the Latency-associated Peptide to Regulate Activation of Latent Transforming Growth Factor-βJournal of Biological Chemistry, 1999
- Keratinocytes in Human Wounds Express αvβ6 IntegrinJournal of Investigative Dermatology, 1996
- Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver diseasePublished by Elsevier ,1993